Literature DB >> 11014457

Neural mechanisms of cutaneous nociceptive pain.

M Koltzenburg1.   

Abstract

Acute mechanical, thermal, and chemically induced pains in the skin are signalled by a set of specific nociceptive afferents, which encode the magnitude of the perceived pain by their discharge intensity. After tissue injury or inflammation, a number of changes in the properties of the primary afferent occur parallel to profound changes in the central nervous system. Primary hyperalgesia (within the area of tissue injury) is best explained by changes of the properties of primary nociceptive afferents, whereas secondary hyperalgesia (increased pain sensitivity outside the area of tissue injury) critically requires functional changes in the central nervous system. Collectively, these changes are the basis for the many forms of hyperalgesia that can present clinically as incident pain. Knowledge of the various types of hyperalgesia and their underlying mechanisms is required for better treatment of this challenging aspect of chronic pain.

Entities:  

Mesh:

Year:  2000        PMID: 11014457     DOI: 10.1097/00002508-200009001-00004

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  17 in total

1.  Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis.

Authors:  T Gutierrez; J N Farthing; A M Zvonok; A Makriyannis; A G Hohmann
Journal:  Br J Pharmacol       Date:  2006-12-11       Impact factor: 8.739

2.  The evolution of primary hyperalgesia in orthopedic surgery: quantitative sensory testing and clinical evaluation before and after total knee arthroplasty.

Authors:  Valéria Martinez; Dominique Fletcher; Didier Bouhassira; Daniel I Sessler; Marcel Chauvin
Journal:  Anesth Analg       Date:  2007-09       Impact factor: 5.108

3.  Preventive and therapeutic effects of a beta adrenoreceptor agonist, dobutamine, in carrageenan-induced inflammatory nociception in rats.

Authors:  Tufan Mert; Berin Tugtag; Metin Kilinc; Elif Sahin; Hafize Oksuz; Yasemin Gunes
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

4.  Etoricoxib--preemptive and postoperative analgesia (EPPA) in patients with laparotomy or thoracotomy--design and protocols.

Authors:  Johannes Fleckenstein; Sybille Kramer; Martin Offenbächer; Gabriel Schober; Herbert Plischke; Matthias Siebeck; Thomas Mussack; Rudolf Hatz; Lukas Lehmeyer; Philip M Lang; Bernhard Heindl; Peter Conzen; Dominik Irnich
Journal:  Trials       Date:  2010-05-27       Impact factor: 2.279

Review 5.  Peripheral and central sensitization in fibromyalgia: pathogenetic role.

Authors:  Roland Staud; Michael L Smitherman
Journal:  Curr Pain Headache Rep       Date:  2002-08

Review 6.  The trigeminocervical complex and migraine: current concepts and synthesis.

Authors:  T Bartsch; Peter J Goadsby
Journal:  Curr Pain Headache Rep       Date:  2003-10

7.  Sox11 transcription factor modulates peripheral nerve regeneration in adult mice.

Authors:  Michael P Jankowski; Sabrina L McIlwrath; Xiaotang Jing; Pamela K Cornuet; Kathleen M Salerno; H Richard Koerber; Kathryn M Albers
Journal:  Brain Res       Date:  2008-12-24       Impact factor: 3.252

8.  Percutaneous alcohol injection under sonographic guidance in Morton's neuroma: follow-up in 220 treated lesions.

Authors:  Luciano Perini; Claudia Perini; Matteo Tagliapietra; Davide Varotto; Andrea Valcarenghi; Andrea Postorino; Antonio Volpe
Journal:  Radiol Med       Date:  2016-02-16       Impact factor: 3.469

9.  Analgesic effect of piracetam on peripheral neuropathic pain induced by chronic constriction injury of sciatic nerve in rats.

Authors:  Ashish K Mehta; Yogendra Bhati; Chakra D Tripathi; Krishna K Sharma
Journal:  Neurochem Res       Date:  2014-05-16       Impact factor: 3.996

10.  The epidemiology and impact of pain in osteoarthritis.

Authors:  T Neogi
Journal:  Osteoarthritis Cartilage       Date:  2013-09       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.